TKDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 14.8 EUR

Market Cap: €46.4B

T	Takeda Pharmaceutical Co Ltd SWB:TKDA	JP
A	Arrow Electronics Inc DUS:ARW	US
	Royalty Pharma PLC F:RPD	US
	Assa Abloy AB OTC:ASAZY	SE
	Coor Service Management Holding AB F:COE	SE
	Graphite India Ltd NSE:GRAPHITE	IN
	Amplify Energy Corp F:2OQ	US
C	Ctac NV F:TAC	NL
D	Dynasty Ceramic PCL SET:DCC	TH
	NetraMark Holdings Inc F:PF0	CA

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

69% > 65%

Low Operating Margin

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

13% > 3%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Declining Net Margin

7% > -4%

Exceptional Free Cash Flow Margin

11%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.